Spinazzé Silvia, Schrijvers Dirk
START Project and Ospedale Reginale, Aosta, Italy.
Crit Rev Oncol Hematol. 2006 Apr;58(1):79-89. doi: 10.1016/j.critrevonc.2005.04.004. Epub 2005 Dec 7.
Life-threatening metabolic complications observed in cancer patients are: hypercalcaemia, hyponatremia, hyperurcaemia, tumour lysis syndrome, hypoglycaemia, hyperuremia and hypercreatininemia secondary to renal failure, hyperammoniemia, lactic acidosis and adrenal failure. They may be associated with any kind of neoplastic disease causing dysfunction of vital organs, which can be determined by neoplastic spread, anti-cancer treatment or, more rarely, by paraneoplastic phenomena. The clinical presentation of metabolic complications is typically aspecific. Encephalopathy, raging from mild confusion to coma, is the most common and clinically most severe symptom. The severity of consciousness impairment is related to both the rate of onset and the magnitude of the metabolic disorder. The definitive diagnosis will be established by laboratory examination and radiological work-up. Cancer patients presenting metabolic should be referred to oncologic departments or intensive care units. The treatment of metabolic disorders include: prophylactic measures, emergency measures to preserve vital functions and to restore biological parameters and the treatment of the underlying primary.
高钙血症、低钠血症、高尿酸血症、肿瘤溶解综合征、低血糖症、继发于肾衰竭的高尿素血症和高肌酐血症、高氨血症、乳酸酸中毒和肾上腺功能衰竭。它们可能与任何导致重要器官功能障碍的肿瘤性疾病相关,这可由肿瘤扩散、抗癌治疗或更罕见的副肿瘤现象决定。代谢并发症的临床表现通常是非特异性的。从轻度意识模糊到昏迷的脑病是最常见且临床上最严重的症状。意识障碍的严重程度与发病速度和代谢紊乱的程度均有关。最终诊断将通过实验室检查和影像学检查来确立。出现代谢问题的癌症患者应转诊至肿瘤科或重症监护病房。代谢紊乱的治疗包括:预防措施、维持重要功能和恢复生物学参数的紧急措施以及对潜在原发疾病的治疗。